688468.SH
Chemclin Diagnostics Co., Ltd.
SSE · Healthcare · Medical - Specialties · CN
CNY 6.01
+1.86%Oct 29, 2026, 07:45 UTC
Kemei Diagnostics reported revenue of RMB 243 million for the first three quarters of 2026, down 6.99% year over year, and net profit attributable to shareholders of RMB 26.2063 million, down 36.95%.
Source:Oct 29, 2026, 07:45 UTC
Kemei Diagnostics reported third-quarter 2026 revenue of RMB 88.1321 million, down 8.39% year over year, and net profit attributable to shareholders of RMB 10.6701 million, down 38.04%.
Source: